November 16, 2024

SEELOS THERAPEUTICS, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 17, 2025

    Biopharma Co. Seelos Gets OK For $22M Ch. 11 Sale

    A New York bankruptcy judge on Wednesday approved the $22 million credit bid sale of bankrupt biopharmaceutical company Seelos Therapeutics after hearing the buyer had agreed to add another $100,000 in cash to its offer.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login